LYNPARZA™ (olaparib) for Advanced Ovarian Cancer - Cancer Therapy Advisor

LYNPARZA™ (olaparib) for Advanced Ovarian Cancer

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for LYNPARZA™ (olaparib), indicated for advanced ovarian cancer.
Table of Contents
Slide 3: Indication, Dosage, and Administration
Slide 7: Use in Specific Populations
Slide 9: Clinical Pharmacology
Slide 13: Warnings and Precautions
Slide 16: Clinical Safety and Efficacy
Slide 21: Drug Storage and Supply
Slide 23: References

Next hm-slideshow in Slides